cov

A new study on Israel's COVID outbreak found that vaccinated individuals had 27 times higher risk of symptomatic COVID infection than those with natural immunity from prior COVID infection. 

We recently discussed the lawsuit filed by a George Mason University professor who refused to get the Covid vaccine upon the recommendation of his doctors and due to his natural antibodies after re…

Quick references and tweet threads you can use in the debate of natural immunity vs. vaccines.

In my book, I recount how slow the federal government was in publicizing the use of Bactrim and other sulfa drugs to prevent PCP (the pneumonia that was then the leading killer of people with AIDS) in addition to its long-time and well-known use to treat PCP.

His stubborn focus on producing a vaccine rather than therapeutics was of particular frustration to activists and other scientists.

In 2015, the Nobel Committee for Physiology or Medicine, in its only award for treatments of infectious diseases since six decades prior, honoured the discovery of ivermectin (IVM), a multifaceted drug deployed against some of the world’s most ...

"The jab" is just the latest story to be reported as mantra

If Internet algorithms can't tell the difference between criticism and advocacy, what's safe to report? Why one filmmaker believes "YouTube is unfit for the purpose for hosting journalism."

Ivermectin, a US Food and Drug Administration-approved anti-parasitic agent, was found to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in vitro. A randomized, double-blind, placebo-controlled trial was conducted to determine the rapidity of viral clearance and saf …

Repurposed medicines may have a role against the SARS-CoV-2 virus. The antiparasitic ivermectin, with antiviral and anti-inflammatory properties, has now been tested in numerous clinical trials.We assessed the efficacy of ivermectin treatment in reducing ...

New RCT article published in Asian Pacific Journal of Tropical Medicine. Niaee, Namdar et al. Concludes that Ivermectin as an adjunct reduces the rate of mortality, time of low O2 saturation, and duration of hospitalization in adult COVID-19 patients. The improvement of other clinical parameters shows that ivermectin, with a wide margin of safety, had a […]

Evidence and Protocols On this page we are listing an ever-growing bank of evidence supporting the use of ivermectin for covid-19. Please bookmark this page and visit regularly to find the latest Protocols, Evidence, Trials and more to show how ivermectin can be used successfully. Latest Research and Protocols More Resources More information can also […]

GERMANY Restricts use to those aged over 60. Recommended on April 1 that people under 60 who have had a first dose of AstraZeneca should receive a different second shot. INDONESIA Is using the vaccine but has warned against giving it to people with a low blood platelet count.

Belgium has suspended the use of the Johnson & Johnson COVID-19 vaccine for people under age 41 following the death of a person who had received the shot

The Danish Health Authority said the risk of unusual blood clots as a side effect of the Johnson & Johnson vaccine outweighed its benefits.

The European Medicines Agency is trying to determine if mRNA vaccines can trigger an allergic skin reaction called erythema multiforme or two kidney disorders. It has requested additional data from Pfizer, BioNTech and Moderna.

BERLIN (AP) — A cascading number of European countries — including Germany, France, Italy and Spain — suspended use of AstraZeneca’s COVID-19 vaccine Monday over reports of dangerous blood clots in some recipients, though the company and international regulators say there is no evidence the shot is to blame...

French health authorities advised against use of the Moderna Covid jab for people under 30 late yesterday, after a nation-wide study confirmed a slight risk of cardiac inflammation associated with mRNA vaccines.

Finland and Sweden are limiting the use of Moderna's Covid-19 vaccine in young people over concerns around rare cardiovascular side effects.

This decision from Iceland has come a little after Sweden and Finland, too, suspended the use of Moderna vaccine for people under the age of 30

Anthony Fauci once was the most trusted man in America on all things COVID-19. That's clearly no longer the case.

As recently as 2018, Fauci celebrated the lifting of the “pause” on such research. With government in “upstream” control of funding, guidance, and publications, he argued, what could go wrong?

The National Institutes of Health admitted Peter Daszak’s EcoHealth Alliance broke its reporting rules when conducting bat coronavirus research, with critics immediately contending this means the Wuhan lab collaborator had indeed been conducting gain-of-function research and NIH lied about it.

The FDA should demand adequate, controlled studies with long term follow up, and make data publicly available, before granting full approval to covid-19 vaccines, says Peter Doshi On 28 July [...]More...

We are part of a group of clinicians, scientists, and patient advocates who have lodged a formal “Citizen Petition” with the United States Food and Drug Administration (FDA), asking the [...]More...

Revelations of poor practices at a contract research company helping to carry out Pfizer’s pivotal covid-19 vaccine trial raise questions about data integrity and regulatory oversight. Paul D Thacker reports In autumn 2020 Pfizer’s chairman and chief executive, Albert Bourla, released an open letter to the billions of people around the world who were investing their hopes in a safe and effective covid-19 vaccine to end the pandemic. “As I’ve said before, we are operating at the speed of science,” Bourla wrote, explaining to the public when they could expect a Pfizer vaccine to be authorised in the United States.1 But, for researchers who were testing Pfizer’s vaccine at several sites in Texas during that autumn, speed may have come at the cost of data integrity and patient safety. A regional director who was employed at the research organisation Ventavia Research Group has told The BMJ that the company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial. Staff who conducted quality control checks were overwhelmed by the volume of problems they were finding. After repeatedly notifying Ventavia of these problems, the regional director, Brook Jackson, emailed a complaint to the US Food and Drug Administration (FDA). Ventavia fired her later the same day. Jackson has provided The BMJ with dozens of internal company documents, photos, audio recordings, and emails. On its website Ventavia calls itself the largest privately owned clinical research company in Texas and lists many awards it has won for its contract work.2 But Jackson has told The BMJ that, during the two weeks she was employed at Ventavia in September 2020, she repeatedly informed her superiors of poor laboratory management, patient safety concerns, and data integrity issues. Jackson was …

Research reveals fully vaccinated people are just as likely to pass virus on to others in their household

Vaccination alone won't stop the rise of new variants and in fact could push the evolution of strains that evade their protection, researchers warned Friday.

The treatment reduced the risk of reaching mechanical ventilation by 44%. ICU admissions were lower by 43%, and an overall in-hospital mortality saw a 47% decrease.